Legend Biotech Corporation (LEGN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -1.298 | -37.104 | -60.171 | -41.994 | -36.447 | -32.599 |
| Return on Equity (%) | -64.377 | 232.835 | -385.647 | -102.789 | -73.442 | -51.938 |
| Return on Invested Capital (%) | 70.943 | 150.882 | -294.857 | -86.866 | -60.141 | -37.23 |
| Operating Margin (%) | -3.122 | -227.275 | -400.937 | -429.112 | -371.717 | -174.763 |
| Net Profit Margin (%) | -5.666 | -232.209 | -401.021 | -430.115 | -381.479 | -181.752 |
| Book Value Per Share | 0.043 | -0.617 | 1.043 | 1.512 | 2.244 | 3.428 |
| Earnings Per Share | -0.014 | -0.665 | -1.141 | -1.252 | -1.352 | -1.424 |
| Cash Per Share | 1.051 | 0.417 | 1.713 | 2.233 | 2.381 | 3.512 |
| Working Capital Per Share | 0.839 | 0.397 | 1.623 | 2.167 | 2.427 | 3.522 |
| Operating Profit Per Share | 0.246 | 0.286 | 0.284 | 0.291 | 0.156 | 0.387 |
| EBIT Per Share | -0.008 | -0.652 | -1.156 | -1.252 | -1.35 | -1.43 |
| EBITDA Per Share | -0.008 | -0.652 | -1.156 | -1.252 | -1.35 | -1.43 |
| Free Cash Flow Per Share | 0.083 | -0.495 | -0.991 | -1.144 | -1.34 | -1.418 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | Mar 2022 | Jun 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | -98.202 | N/A | -294.089 | N/A | N/A | N/A | -57.785 | N/A |
| Net Profit Margin (%) | -100.637 | N/A | -308.512 | N/A | N/A | N/A | -63.616 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 5.96B |
| Price to Earnings Ratio | 0 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 181.91M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
